Company Nanexa AB

Equities

NANEXA

SE0007074166

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Stockholm 11:29:47 2024-04-25 am EDT 5-day change 1st Jan Change
0.64 SEK -0.62% Intraday chart for Nanexa AB +0.63% -47.97%

Business Summary

Nanexa AB is a Sweden-based company engaged in the drug delivery systems industry. The Company specializes in the nanotechnology and research and development in life science. Its products portfolio is comprised of PharmaShell, a drug delivery system that allows for targeting and dosing of drugs; antifungal coating, a system that protects medical products from the in-growth of fungi; and low-friction coating for peripheral venous catheters.

Number of employees: 19

Sales per Business

SEK in Million2022Weight2023Weight Delta
Pharmaceutical
100.0 %
3 100.0 % 29 100.0 % +925.42%

Sales per region

SEK in Million2022Weight2023Weight Delta
Nordic Countries
86.1 %
1 35.4 % 25 86.1 % +2,392.30%
North America
13.7 %
2 64.6 % 4 13.7 % +117.11%
Asia
0.2 %
-- 0 0.2 % -

Managers

Managers TitleAgeSince
Founder 47 06-12-31
Founder 48 06-12-31
Chief Executive Officer 64 15-03-31
Director of Finance/CFO 53 18-12-31
Chief Tech/Sci/R&D Officer 61 16-12-31
Corporate Officer/Principal 41 15-12-31
General Counsel 59 -
Corporate Officer/Principal 63 15-12-31
Corporate Officer/Principal 62 14-12-31

Members of the board

Members of the board TitleAgeSince
Chairman 75 20-06-01
Director/Board Member 69 22-12-31
Corporate Officer/Principal 62 14-12-31
Director/Board Member 75 20-12-31
Director/Board Member 60 -
Director/Board Member 51 21-12-31
Director/Board Member 73 15-01-31
Founder 47 06-12-31
Chief Tech/Sci/R&D Officer 61 16-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 135,695,626 104,148,131 ( 76.75 %) 0 76.75 %

Company contact information

Nanexa AB

Virdings Allé 32B

754 50, Uppsala

+46 18 10 03 00

http://nanexa.se
address Nanexa AB(NANEXA)